Matthew T. Wiley
Chief Commercial Officer at Definium Therapeutics, Inc. (DFTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $242K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 29SEC | DFTXDefinium Therapeutics, Inc. | Sell Plan | 3,097359,036 held (−1%) | $36.57 | $113K | -12.2% |
| Jun 26SEC | DFTXDefinium Therapeutics, Inc. | Sell Plan | 2,867174,633 held (−2%) | $45.03 | $129K | -28.7% |
- Sell
Chief Commercial Officer Matthew T. Wiley sold $113K of DFTX at $36.57 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Matthew T. Wiley sold $129K of DFTX at $45.03 — pre-scheduled 10b5-1 plan sale.